45.
Kiralj R., Ferreira M. M. C., Pinheiro J. C., Romero O. A. S., “Combined
QSAR, Molecular Graphics and Modeling Study on Some C9, C10-substituted
Artemisinins with Antimalarial Activity Against Plasmodium Falciparum”.
Bournemouth, United Kingdom, 08-13/09/2002: 14th European Symposium
on Quantitative Structure-Activity Relationships: Designing Drugs - Problems
and Solutions (Euro QSAR 2002), Final Programme Book, Poster
No. 045.
Here below are some internet sources of information about the EuroQSAR
2002 meeting.
http://www.ccl.net/cca/info/conferencelist/mess0986.shtml |
CCL mess0986 | |||||||||||||||||||
|
From jkl@osc.edu Fri Feb 15 12:49:11 2002 -0500 From: martyn.ford@port.ac.uk To: dabraham@gems.vcu.edu, m.h.abraham@ucl.ac.uk, zefirov@org.chem.msk.su, mjzehe@grc.nasa.gov, litai_zhang@fmc.com, xizst5+@pitt.edu, zotov@qsar.chem.msu.su, zsolt@simbiosys.ca MIME-Version: 1.0 Content-type: text/enriched; charset=ISO-8859-1 Content-transfer-encoding: Quoted-printable Subject: 02.09.08 Euro QSAR 2002: Designing Drugs and Crop Protectants - Bournemouth, UK The Bournemouth International Centre is one of the most prestigious conference venues in the UK, regularly playing host to major political parties and international performing artists. We've chosen this purpose-built centre as the venue for the 14th European Symposium on Quantitative Structure-Activity Relationships 2002: Designing Drugs and Agrochemicals =96 Processes, Problems and Solutions. The meeting will take place between Sunday 8th and Friday 13th September, 2002. Further details can be found on the symposium website at ( www.euro-qsar.org ). Robotics, information technology, microprocessor technology and miniaturisation are affecting the way biologically active compounds are discovered and designed. We're developing a scientific programme to focus on the impact of these new technologies. We will identify important problems remaining to be solved and review the roles that QSAR and Molecular Modelling can play in achieving this goal. A strong scientific programme, internationally recognised speakers and chairmen, poster sessions and workshops, an industrial exhibition, and a memorable social programme: we will create a culture of discussion that continues to thrive outside the lecture hall. Invited speakers include Graham Richards (Oxford), Tim Clark (Erlangen), Dave Weininger (Santa Fe), Gert Vriend () and Peter Willett (Sheffield). Peter Machin, Senior Vice President of GSK has agreed to present the opening lecture. Your input will ensure that the focus of the meeting addresses your company's current and future industrial requirements. Please let us have your thoughts and ideas on the programme content. If you are employed by a commercial or industrial company, your support could be crucial to the success of this meeting. We have set a target of to raise through corporate sponsorship. The sponsorship fund will be used to support the costs of invited speakers, chairmen, student bursaries, receptions, poster prizes and promotion. We would like to invite you to make a donation, either for sponsorship of a specific event or publication, or for a contribution to the general fund. In return for a donation, your company will receive excellent publicity and wide exposure, both on the website ( www.euro-qsar.org ) and throughout the meeting. All sponsors will be publicly acknowledged and named in the proceedings. We hope you will feel able to make a generous contribution. Please reply to: martyn.ford@port.ac.uk or Nicki.Cordery@qclscientific.com |
|
|
Session organiser: David Manallack, De Novo Pharmaceuticals, Cambridge, UK
Presenters: Han Van de Waterbeemd, Mine Yarim, Peter Hunt, John
Dearden, Alanas Petrauskas
Han Van de Waterbeemd
Transporters: Introduction and importance to
ADME studies"
Peter Hunt
P-glycoprotein modelling - Is a straight line
always the best way...?
John Dearden
QSAR of Pgp efflux
Mine Yarim
A comparative molecular field analysis of organic
anion transporting polypeptide 3 (Oatp3) substrates
Alanas Petrauskas
Classification SAR in the prediction of P-glycoprotein
substrate specificity